The U.S. Is Running Out Of A Critical Childhood Cancer Drug And There Is No Suitable Replacement.
The U.S. is experiencing a critical shortage of a drug called vincristine, used to treat several types of childhood cancer including leukemias and lymphomas after one of the only two U.S. manufacturers, Teva Pharmaceutical decided to discontinue production in July.